Aloe-Emodin Overcomes Anti-Cancer Drug Resistance to Temozolomide and Prevents Colony Formation and Migration in Primary Human Glioblastoma Cell Lines NULU and ZAR

Glioblastoma, the most dangerous and aggressive type of CNS tumor, appears resistant to many chemotherapy drugs. In the patient-derived glioma cell lines NULU and ZAR, which exhibit drug-resistant phenotypes, we investigated the effect of combined AE (Aloe-emodin) and TMZ (temozolomide) and found a...

Full description

Saved in:
Bibliographic Details
Published in:Molecules (Basel, Switzerland) Switzerland), 2023-08, Vol.28 (16), p.6024
Main Authors: Staffieri, Sabrina, Russo, Veronica, Oliva, Maria Antonietta, Alborghetti, Marika, Russo, Miriam, Arcella, Antonietta
Format: Article
Language:English
Subjects:
aloe-emodin (AE)
Alzheimer's disease
Apoptosis
autophagy
Brain cancer
Brain research
Cancer
Cancer therapies
Cell growth
Chemotherapy
Comparative analysis
Computer software industry
Cytotoxicity
DNA methylation
DNA repair
Drug resistance
Drug therapy
Enzymes
Genotype & phenotype
glioblastoma (GBM)
Glioblastoma multiforme
Glioma
Medical prognosis
MGMT
Patients
Phytochemicals
Prevention
Protein expression
Proteins
Radiation therapy
Stem cells
Temozolomide
temozolomide (TMZ)
Toxicity
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c538t-642fc72c61b4ffe6ea8eeeae0298378f2e5208e37be1d3365f874599b76e1bd13
cites cdi_FETCH-LOGICAL-c538t-642fc72c61b4ffe6ea8eeeae0298378f2e5208e37be1d3365f874599b76e1bd13
container_end_page
container_issue 16
container_start_page 6024
container_title Molecules (Basel, Switzerland)
container_volume 28
creator Staffieri, Sabrina
Russo, Veronica
Oliva, Maria Antonietta
Alborghetti, Marika
Russo, Miriam
Arcella, Antonietta
description Glioblastoma, the most dangerous and aggressive type of CNS tumor, appears resistant to many chemotherapy drugs. In the patient-derived glioma cell lines NULU and ZAR, which exhibit drug-resistant phenotypes, we investigated the effect of combined AE (Aloe-emodin) and TMZ (temozolomide) and found a significant additive inhibitory effect on cell growth and a promising cytotoxic effect on both cell lines compared to treatment with single agents. We also examined the effect of combined AE and TMZ treatment on the drug-resistance protein MGMT. The results suggest that using AE combined with traditional drugs restores drug resistance in both primary resistant cell lines (NULU and ZAR). Furthermore, migration assays and scratch tests showed that the combined use of AE and TMZ can slow down the colony formation and migration of glioblastoma cells. These convincing results suggest that AE could be a natural adjuvant agent to potentiate the effects of traditional drugs (TMZ) and overcome drug resistance in glioblastoma cells.
doi_str_mv 10.3390/molecules28166024
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_33152598c5374edaac2f427f0dad6d8f</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A762483659</galeid><doaj_id>oai_doaj_org_article_33152598c5374edaac2f427f0dad6d8f</doaj_id><sourcerecordid>A762483659</sourcerecordid><originalsourceid>FETCH-LOGICAL-c538t-642fc72c61b4ffe6ea8eeeae0298378f2e5208e37be1d3365f874599b76e1bd13</originalsourceid><addsrcrecordid>eNptUk1v1DAQjRCIlsIP4GaJC5cUf8VxTmi1_ZQWWlXdCxfLcSaLV7Fd7GSl8nf4o3h3K2AB-WD7zZs3M88uircEnzLW4A8uDGCmARKVRAhM-bPimHCKS4Z58_yP81HxKqU1xpRwUr0sjlgtGKa1OC5-zIYA5bkLnfXoZgPRBAcJzfxoy7n2BiI6i9MK3UGyadwCaAzoHlz4HobgbAdI-w7dRtiAHxOaZ9Q_oosQnR5t8LvoJ7uK-1suchut0_ERXU1Oe3Q52NAOOo3BaTSHYUAL63MDn5eL5S73y-zudfGi10OCN0_7SbG8OL-fX5WLm8vr-WxRmorJsRSc9qamRpCW9z0I0BIANGDaSFbLnkJFsQRWt0A6xkTVy5pXTdPWAkjbEXZSXO91u6DX6mHfpwraqh0Q4krpOFozgGKMVLRqZK5cc-i0NrTntO5xpzvRyT5rfdxrPUytg85kc6IeDkQPI95-VauwUQTzSpJKZIX3TwoxfJsgjcrZZLJD2kOYkqKyqmWVn5Rm6ru_qOswRZ-92rE44aLiv1krnSewvg-5sNmKqlktKJfZkiazTv_DyqsDZ03w0NuMHySQfYKJIaUI_a8hCVbbb6r--absJ75H3Fc</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2857414654</pqid></control><display><type>article</type><title>Aloe-Emodin Overcomes Anti-Cancer Drug Resistance to Temozolomide and Prevents Colony Formation and Migration in Primary Human Glioblastoma Cell Lines NULU and ZAR</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Staffieri, Sabrina ; Russo, Veronica ; Oliva, Maria Antonietta ; Alborghetti, Marika ; Russo, Miriam ; Arcella, Antonietta</creator><creatorcontrib>Staffieri, Sabrina ; Russo, Veronica ; Oliva, Maria Antonietta ; Alborghetti, Marika ; Russo, Miriam ; Arcella, Antonietta</creatorcontrib><description>Glioblastoma, the most dangerous and aggressive type of CNS tumor, appears resistant to many chemotherapy drugs. In the patient-derived glioma cell lines NULU and ZAR, which exhibit drug-resistant phenotypes, we investigated the effect of combined AE (Aloe-emodin) and TMZ (temozolomide) and found a significant additive inhibitory effect on cell growth and a promising cytotoxic effect on both cell lines compared to treatment with single agents. We also examined the effect of combined AE and TMZ treatment on the drug-resistance protein MGMT. The results suggest that using AE combined with traditional drugs restores drug resistance in both primary resistant cell lines (NULU and ZAR). Furthermore, migration assays and scratch tests showed that the combined use of AE and TMZ can slow down the colony formation and migration of glioblastoma cells. These convincing results suggest that AE could be a natural adjuvant agent to potentiate the effects of traditional drugs (TMZ) and overcome drug resistance in glioblastoma cells.</description><identifier>ISSN: 1420-3049</identifier><identifier>EISSN: 1420-3049</identifier><identifier>DOI: 10.3390/molecules28166024</identifier><identifier>PMID: 37630276</identifier><language>eng</language><publisher>Basel: MDPI AG</publisher><subject>aloe-emodin (AE) ; Alzheimer's disease ; Apoptosis ; autophagy ; Brain cancer ; Brain research ; Cancer ; Cancer therapies ; Cell growth ; Chemotherapy ; Comparative analysis ; Computer software industry ; Cytotoxicity ; DNA methylation ; DNA repair ; Drug resistance ; Drug therapy ; Enzymes ; Genotype &amp; phenotype ; glioblastoma (GBM) ; Glioblastoma multiforme ; Glioma ; Medical prognosis ; MGMT ; Patients ; Phytochemicals ; Prevention ; Protein expression ; Proteins ; Radiation therapy ; Stem cells ; Temozolomide ; temozolomide (TMZ) ; Toxicity</subject><ispartof>Molecules (Basel, Switzerland), 2023-08, Vol.28 (16), p.6024</ispartof><rights>COPYRIGHT 2023 MDPI AG</rights><rights>2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2023 by the authors. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c538t-642fc72c61b4ffe6ea8eeeae0298378f2e5208e37be1d3365f874599b76e1bd13</citedby><cites>FETCH-LOGICAL-c538t-642fc72c61b4ffe6ea8eeeae0298378f2e5208e37be1d3365f874599b76e1bd13</cites><orcidid>0009-0000-0463-4914 ; 0000-0002-0708-8282</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2857414654/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2857414654?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25731,27901,27902,36989,36990,44566,53766,53768,74869</link.rule.ids></links><search><creatorcontrib>Staffieri, Sabrina</creatorcontrib><creatorcontrib>Russo, Veronica</creatorcontrib><creatorcontrib>Oliva, Maria Antonietta</creatorcontrib><creatorcontrib>Alborghetti, Marika</creatorcontrib><creatorcontrib>Russo, Miriam</creatorcontrib><creatorcontrib>Arcella, Antonietta</creatorcontrib><title>Aloe-Emodin Overcomes Anti-Cancer Drug Resistance to Temozolomide and Prevents Colony Formation and Migration in Primary Human Glioblastoma Cell Lines NULU and ZAR</title><title>Molecules (Basel, Switzerland)</title><description>Glioblastoma, the most dangerous and aggressive type of CNS tumor, appears resistant to many chemotherapy drugs. In the patient-derived glioma cell lines NULU and ZAR, which exhibit drug-resistant phenotypes, we investigated the effect of combined AE (Aloe-emodin) and TMZ (temozolomide) and found a significant additive inhibitory effect on cell growth and a promising cytotoxic effect on both cell lines compared to treatment with single agents. We also examined the effect of combined AE and TMZ treatment on the drug-resistance protein MGMT. The results suggest that using AE combined with traditional drugs restores drug resistance in both primary resistant cell lines (NULU and ZAR). Furthermore, migration assays and scratch tests showed that the combined use of AE and TMZ can slow down the colony formation and migration of glioblastoma cells. These convincing results suggest that AE could be a natural adjuvant agent to potentiate the effects of traditional drugs (TMZ) and overcome drug resistance in glioblastoma cells.</description><subject>aloe-emodin (AE)</subject><subject>Alzheimer's disease</subject><subject>Apoptosis</subject><subject>autophagy</subject><subject>Brain cancer</subject><subject>Brain research</subject><subject>Cancer</subject><subject>Cancer therapies</subject><subject>Cell growth</subject><subject>Chemotherapy</subject><subject>Comparative analysis</subject><subject>Computer software industry</subject><subject>Cytotoxicity</subject><subject>DNA methylation</subject><subject>DNA repair</subject><subject>Drug resistance</subject><subject>Drug therapy</subject><subject>Enzymes</subject><subject>Genotype &amp; phenotype</subject><subject>glioblastoma (GBM)</subject><subject>Glioblastoma multiforme</subject><subject>Glioma</subject><subject>Medical prognosis</subject><subject>MGMT</subject><subject>Patients</subject><subject>Phytochemicals</subject><subject>Prevention</subject><subject>Protein expression</subject><subject>Proteins</subject><subject>Radiation therapy</subject><subject>Stem cells</subject><subject>Temozolomide</subject><subject>temozolomide (TMZ)</subject><subject>Toxicity</subject><issn>1420-3049</issn><issn>1420-3049</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptUk1v1DAQjRCIlsIP4GaJC5cUf8VxTmi1_ZQWWlXdCxfLcSaLV7Fd7GSl8nf4o3h3K2AB-WD7zZs3M88uircEnzLW4A8uDGCmARKVRAhM-bPimHCKS4Z58_yP81HxKqU1xpRwUr0sjlgtGKa1OC5-zIYA5bkLnfXoZgPRBAcJzfxoy7n2BiI6i9MK3UGyadwCaAzoHlz4HobgbAdI-w7dRtiAHxOaZ9Q_oosQnR5t8LvoJ7uK-1suchut0_ERXU1Oe3Q52NAOOo3BaTSHYUAL63MDn5eL5S73y-zudfGi10OCN0_7SbG8OL-fX5WLm8vr-WxRmorJsRSc9qamRpCW9z0I0BIANGDaSFbLnkJFsQRWt0A6xkTVy5pXTdPWAkjbEXZSXO91u6DX6mHfpwraqh0Q4krpOFozgGKMVLRqZK5cc-i0NrTntO5xpzvRyT5rfdxrPUytg85kc6IeDkQPI95-VauwUQTzSpJKZIX3TwoxfJsgjcrZZLJD2kOYkqKyqmWVn5Rm6ru_qOswRZ-92rE44aLiv1krnSewvg-5sNmKqlktKJfZkiazTv_DyqsDZ03w0NuMHySQfYKJIaUI_a8hCVbbb6r--absJ75H3Fc</recordid><startdate>20230801</startdate><enddate>20230801</enddate><creator>Staffieri, Sabrina</creator><creator>Russo, Veronica</creator><creator>Oliva, Maria Antonietta</creator><creator>Alborghetti, Marika</creator><creator>Russo, Miriam</creator><creator>Arcella, Antonietta</creator><general>MDPI AG</general><general>MDPI</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0009-0000-0463-4914</orcidid><orcidid>https://orcid.org/0000-0002-0708-8282</orcidid></search><sort><creationdate>20230801</creationdate><title>Aloe-Emodin Overcomes Anti-Cancer Drug Resistance to Temozolomide and Prevents Colony Formation and Migration in Primary Human Glioblastoma Cell Lines NULU and ZAR</title><author>Staffieri, Sabrina ; Russo, Veronica ; Oliva, Maria Antonietta ; Alborghetti, Marika ; Russo, Miriam ; Arcella, Antonietta</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c538t-642fc72c61b4ffe6ea8eeeae0298378f2e5208e37be1d3365f874599b76e1bd13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>aloe-emodin (AE)</topic><topic>Alzheimer's disease</topic><topic>Apoptosis</topic><topic>autophagy</topic><topic>Brain cancer</topic><topic>Brain research</topic><topic>Cancer</topic><topic>Cancer therapies</topic><topic>Cell growth</topic><topic>Chemotherapy</topic><topic>Comparative analysis</topic><topic>Computer software industry</topic><topic>Cytotoxicity</topic><topic>DNA methylation</topic><topic>DNA repair</topic><topic>Drug resistance</topic><topic>Drug therapy</topic><topic>Enzymes</topic><topic>Genotype &amp; phenotype</topic><topic>glioblastoma (GBM)</topic><topic>Glioblastoma multiforme</topic><topic>Glioma</topic><topic>Medical prognosis</topic><topic>MGMT</topic><topic>Patients</topic><topic>Phytochemicals</topic><topic>Prevention</topic><topic>Protein expression</topic><topic>Proteins</topic><topic>Radiation therapy</topic><topic>Stem cells</topic><topic>Temozolomide</topic><topic>temozolomide (TMZ)</topic><topic>Toxicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Staffieri, Sabrina</creatorcontrib><creatorcontrib>Russo, Veronica</creatorcontrib><creatorcontrib>Oliva, Maria Antonietta</creatorcontrib><creatorcontrib>Alborghetti, Marika</creatorcontrib><creatorcontrib>Russo, Miriam</creatorcontrib><creatorcontrib>Arcella, Antonietta</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Molecules (Basel, Switzerland)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Staffieri, Sabrina</au><au>Russo, Veronica</au><au>Oliva, Maria Antonietta</au><au>Alborghetti, Marika</au><au>Russo, Miriam</au><au>Arcella, Antonietta</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Aloe-Emodin Overcomes Anti-Cancer Drug Resistance to Temozolomide and Prevents Colony Formation and Migration in Primary Human Glioblastoma Cell Lines NULU and ZAR</atitle><jtitle>Molecules (Basel, Switzerland)</jtitle><date>2023-08-01</date><risdate>2023</risdate><volume>28</volume><issue>16</issue><spage>6024</spage><pages>6024-</pages><issn>1420-3049</issn><eissn>1420-3049</eissn><abstract>Glioblastoma, the most dangerous and aggressive type of CNS tumor, appears resistant to many chemotherapy drugs. In the patient-derived glioma cell lines NULU and ZAR, which exhibit drug-resistant phenotypes, we investigated the effect of combined AE (Aloe-emodin) and TMZ (temozolomide) and found a significant additive inhibitory effect on cell growth and a promising cytotoxic effect on both cell lines compared to treatment with single agents. We also examined the effect of combined AE and TMZ treatment on the drug-resistance protein MGMT. The results suggest that using AE combined with traditional drugs restores drug resistance in both primary resistant cell lines (NULU and ZAR). Furthermore, migration assays and scratch tests showed that the combined use of AE and TMZ can slow down the colony formation and migration of glioblastoma cells. These convincing results suggest that AE could be a natural adjuvant agent to potentiate the effects of traditional drugs (TMZ) and overcome drug resistance in glioblastoma cells.</abstract><cop>Basel</cop><pub>MDPI AG</pub><pmid>37630276</pmid><doi>10.3390/molecules28166024</doi><orcidid>https://orcid.org/0009-0000-0463-4914</orcidid><orcidid>https://orcid.org/0000-0002-0708-8282</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1420-3049
ispartof Molecules (Basel, Switzerland), 2023-08, Vol.28 (16), p.6024
issn 1420-3049
1420-3049
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_33152598c5374edaac2f427f0dad6d8f
source Publicly Available Content Database; PubMed Central
subjects aloe-emodin (AE)
Alzheimer's disease
Apoptosis
autophagy
Brain cancer
Brain research
Cancer
Cancer therapies
Cell growth
Chemotherapy
Comparative analysis
Computer software industry
Cytotoxicity
DNA methylation
DNA repair
Drug resistance
Drug therapy
Enzymes
Genotype & phenotype
glioblastoma (GBM)
Glioblastoma multiforme
Glioma
Medical prognosis
MGMT
Patients
Phytochemicals
Prevention
Protein expression
Proteins
Radiation therapy
Stem cells
Temozolomide
temozolomide (TMZ)
Toxicity
title Aloe-Emodin Overcomes Anti-Cancer Drug Resistance to Temozolomide and Prevents Colony Formation and Migration in Primary Human Glioblastoma Cell Lines NULU and ZAR
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T22%3A45%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Aloe-Emodin%20Overcomes%20Anti-Cancer%20Drug%20Resistance%20to%20Temozolomide%20and%20Prevents%20Colony%20Formation%20and%20Migration%20in%20Primary%20Human%20Glioblastoma%20Cell%20Lines%20NULU%20and%20ZAR&rft.jtitle=Molecules%20(Basel,%20Switzerland)&rft.au=Staffieri,%20Sabrina&rft.date=2023-08-01&rft.volume=28&rft.issue=16&rft.spage=6024&rft.pages=6024-&rft.issn=1420-3049&rft.eissn=1420-3049&rft_id=info:doi/10.3390/molecules28166024&rft_dat=%3Cgale_doaj_%3EA762483659%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c538t-642fc72c61b4ffe6ea8eeeae0298378f2e5208e37be1d3365f874599b76e1bd13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2857414654&rft_id=info:pmid/37630276&rft_galeid=A762483659&rfr_iscdi=true